Prof. Dr. med. Welge-Lüssen explores how vitreous floaters impact patients' daily lives and presents VitroCap®N as a straightforward, non-invasive solution. He breaks down the science behind micronutrient therapy, shares key findings from the FLIES study, and draws on over a decade of real-world clinical experience with VitroCap®N.

Talk overview (time stamps):

• 00:00 – Introduction: Vitreous floaters and patient burden
• 01:15 – Structure and age-related changes of the vitreous
• 02:00 – Pathogenesis of vitreous floaters
• 04:00 – Impact of floaters on patients’ quality of life
• 05:15 – Risk factors and visual disturbances
• 06:30 – Measuring floaters: contrast sensitivity and OCT
• 08:45 – Current treatment options: YAG laser and vitrectomy
• 10:00 – Micronutrient therapy: introducing VitroCap®N
• 12:20 – Clinical evidence: the FLIES study
• 16:45 – Real-world experience and practical use of VitroCap®N
• 22:40 – Final summary: micronutrients for vitreous floaters

“Vitreous floaters cause a great deal of disturbance for these patients, and they really suffer from them. [...] To sum up the FLIES study: we could clearly demonstrate in this placebo-controlled, double-blind study that there was a reduction in floaters, an increase in visual comfort, an increase in visual contrast sensitivity, and also an improvement in daily visual experience. [...] And what is also very important for me as a doctor is that I have never seen any side effects of VitroCap®N.”